Dr. Gerry Schellenberg is Co-PI of Project 1. Dr. Schellenberg has extensive experience in human molecular genetic studies that include linkage analysis and other family-based methods, genome-wide association studies, and mutation and variant detection with Sanger-based and Next Generation-based DNA sequencing methods. Throughout his career, he has been highly productive with over 300 peer-reviewed publications, most related to human disease genetics and incorporating the development and utilization of various model organisms. His main research interest is neurodegenerative diseases, particularly AD and PSP, though he also works on the genetics of autism. His most recent work focuses on genome-wide association studies and discovery of rare variants by rare-variant genotyping arrays, Haplotype Reference Consortium imputation, and Next Generation sequence data.